Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.

Infection and Immunity
S J CryzR Germanier

Abstract

The protective capacity of passively transferred immunoglobulin G (IgG) fractions from antitoxin (AT-IgG), antielastase (AE-IgG), and antilipopolysaccharide (ALPS-IgG) against Pseudomonas aeruginosa infection was evaluated in a murine burn wound sepsis model. Complete protection was afforded by homologous ALPS-IgG against intermediate challenge doses (10 50% lethal doses) of P. aeruginosa PA220, whereas AT-IgG and AE-IgG offered no significant protection (P less than 0.5). The simultaneous transfer of AT-IgG or AE-IgG with ALPS-IgG gave no additional protection above that seen with ALPS-IgG alone. The transfer of ALPS-IgG did not dramatically alter bacterial multiplication in the skin at the site of infection. However, bacteremia and infection of the liver were prevented. In parallel experiments, AT-IgG or AE-IgG did not significantly alter either the course of the infection or the number of bacteria seen in the blood, liver, or skin when compared with controls. ALPS-IgG administered 24 h before infection, at the time of infection, or 4 h postinfection provided complete protection. Even when ALPS-IgG was transferred at a time when the infection was well established locally in the skin (8 h postinfection), highly significant pro...Continue Reading

References

Jun 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·B H Iglewski, D Kabat
Feb 1, 1977·Journal of Clinical Pathology·K Bridges, E J Lowbury
Feb 1, 1977·Journal of Medical Microbiology·J M MilerE J Lowbury
Dec 1, 1977·Infection and Immunity·O R PavlovskisB H Iglewski
Sep 1, 1979·Infection and Immunity·H L WalkerA D Mason
Nov 1, 1974·The Journal of Infectious Diseases·J WesleyM W Fisher
Nov 1, 1974·The Journal of Infectious Diseases·L S Young
Oct 1, 1970·The American Journal of the Medical Sciences·J P WhitecarG P Bodey
Jul 1, 1973·CRC Critical Reviews in Clinical Laboratory Sciences·P NathanB G MacMillan
Feb 1, 1973·The Journal of Surgical Research·C E JonesM Fisher
Jul 1, 1970·The Journal of Trauma·J W Alexander, M W Fisher
Jan 1, 1982·Infection and Immunity·I A HolderT C Montie
Jan 1, 1982·Journal of Clinical Microbiology·K E CroweD C Straus
Oct 1, 1980·The Journal of Infectious Diseases·D E OhmanB H Iglewski

❮ Previous
Next ❯

Citations

Jan 1, 1990·Critical Reviews in Microbiology·Y A Knirel
Jun 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J E Pennington
Apr 1, 1985·European Journal of Clinical Microbiology·D Martinez, L T Callahan
Apr 11, 2001·The Journal of Biological Chemistry·D W KeizerB D Sykes
Jun 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A BraunerB Wretlind
Dec 1, 1998·The Journal of Peptide Research : Official Journal of the American Peptide Society·P J CachiaR S Hodges
May 1, 1989·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A R Ogaard, B P Berdal
Jul 25, 2008·The Journal of Craniofacial Surgery·Nisha PolavarapuZubin Jal Panthaki
Jan 1, 1987·Microbiology and Immunology·H SuzukiT Hozumi
Jun 1, 1985·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·A R OgaardB P Berdal
Aug 14, 2001·Infection and Immunity·I A HolderD W Frank
Apr 1, 1985·European Journal of Clinical Microbiology·S J CryzR Germanier
Jun 1, 1993·FEMS Immunology and Medical Microbiology·A B LangS J Cryz
Jun 1, 1991·Infection and Immunity·M J PrestonR S Berk
Jul 3, 1999·Clinical and Diagnostic Laboratory Immunology·T MatsumotoK Yamaguchi
Apr 1, 1986·Infection and Immunity·S J CryzR Germanier
Jul 1, 1984·Infection and Immunity·P S Holt, M L Misfeldt
May 1, 1984·Infection and Immunity·S J CryzR Germanier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.